Evidence map›Paper›PMID 31730000›Full record

ArticleJournal of experimental & clinical cancer research : CR2019

USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis.

Yuchong Peng, Youhong Liu, Yingxue Gao, Bowen Yuan, Xuli Qi, Yuxin Fu, Qianling Zhu, Tuoyu Cao, Songwei Zhang, Linglong Yin and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yuchong PengCenter for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, China.
Youhong LiuCenter for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, China.
Yingxue GaoCenter for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, China.
Bowen YuanDepartment of Pathology, The Third Xiangya Hospital, Central South University, Changsha, China.
Xuli QiCenter for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, China.
Yuxin FuCenter for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, China.
Qianling ZhuCenter for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, China.
Tuoyu CaoCenter for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, China.
Songwei ZhangCenter for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, China.
Linglong YinCenter for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, China.
Xiong LiCenter for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, China. lixiongxiangya@csu.edu.cn.
Xiangya Hospital Central South University · CNCentral South University · CN

Funding

National Natural Science Foundation of China NSFC, 81572542National Natural Science Foundation of China NSFC, 81874196
6 · The paper itself

Abstract

backgroundThe deubiquitinase USP7 has been identified as an oncogene with key roles in tumorigenesis and therapeutic resistance for a series of cancer types. Recently small molecular inhibitors have been developed to target USP7. However, the anticancer mechanism of USP7 inhibitors is still elusive.

methodsCell viability or clonogenicity was tested by violet crystal assay. Cell apoptosis or cell cycle was analyzed by flow cytometry, and chromosome misalignment was observed by a fluorescent microscopy. The protein interaction of PLK1 and USP7 was detected by tandem affinity purification and high throughput proteomics, and further confirmed by co-immunoprecipitation, GST pull-down and protein co-localization. The correlation between USP7 level of tumor tissues and taxane-resistance was evaluated.

resultsPharmacological USP7 inhibition by P5091 retarded cell proliferation and induced cell apoptosis. Further studies showed that P5091 induced cell cycle arrest at G2/M phase, and particularly induced chromosome misalignment, indicating the key roles of USP7 in mitosis. USP7 protein was detected in the PLK1-interacted protein complex. USP7 interacts with PLK1 protein through its PBD domain by catalytic activity. USP7 as a deubiquitinase sustained PLK1 protein stability via the C223 site, and inversely, USP7 inhibition by P5091 promoted the protein degradation of PLK1 through the ubiquitination-proteasome pathway. By overexpressing PLK1, USP7 that had been depleted by RNAi ceased to induce chromosome misalignment in mitosis and again supported cell proliferation and cell survival. Both USP7 and PLK1 were overexpressed in taxane-resistant cancer cells, and negatively correlated with the MP scores in tumor tissues. Either USP7 or PLK1 knockdown by RNAi significantly sensitized taxane-resistant cells to taxane cell killing.

conclusionThis is the first report that PLK1 is a novel substrate of USP7 deubiquitinase, and that USP7 sustained the protein stability of PLK1. USP7 inhibition induces cell apoptosis and cell cycle G2/M arrest, and overcomes taxane resistance by inducing the protein degradation of PLK1, resulting in chromosome misalignment in mitosis.

Indexed as

ApoptosisCell Cycle ProteinsChromosomesChromosomes, HumanDocetaxelDrug Resistance, NeoplasmG2 Phase Cell Cycle CheckpointsHEK293 CellsHumansMaleMitosisM Phase Cell Cycle CheckpointsNasopharyngeal NeoplasmsPolo-Like Kinase 1Prostatic NeoplasmsProtease InhibitorsCell Cycle ProteinsDocetaxelP5091Polo-Like Kinase 1Protease InhibitorsProtein Serine-Threonine KinasesProto-Oncogene ProteinsThiophenesUbiquitin-Specific Peptidase 7USP7 protein, humanApoptosisCell cycle arrestChromosome misalignmentPLK1USP7

Identifiers

PMID31730000
PMCPMC6858727
OpenAlexW2986255163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.